Thromb Haemost 1967; 17(03/04): 585-594
DOI: 10.1055/s-0038-1654183
Originalarbeiten - Original Articles - Travaux Originaux
Schattauer GmbH

Coagulation Factors in Pregnant Women and Premature Infants with and without the Respiratory Distress Syndrome[*]

Marguerite Markarian M. D.**
1   Department of Pediatrics, University of Colorado Medical Center, Denver, Colorado and the Department of Obstetrics, Hospital San Borja, University of Chile, Santiago (Chile)
,
Annabelle Lindley
1   Department of Pediatrics, University of Colorado Medical Center, Denver, Colorado and the Department of Obstetrics, Hospital San Borja, University of Chile, Santiago (Chile)
,
Jacqueline J. Jackson B. A.,
1   Department of Pediatrics, University of Colorado Medical Center, Denver, Colorado and the Department of Obstetrics, Hospital San Borja, University of Chile, Santiago (Chile)
,
Anne Bannon M. D.
1   Department of Pediatrics, University of Colorado Medical Center, Denver, Colorado and the Department of Obstetrics, Hospital San Borja, University of Chile, Santiago (Chile)
› Author Affiliations
Further Information

Publication History

Publication Date:
26 June 2018 (online)

Summary

Coagulation factors (accelerator globulin, antihemophilic globulin, specific prothrombin, proconvertin complex and Stuart-Prower factor) in 82 low birth weight infants (750–1750 g), 22 normal adult controls and 38 pregnant women prior to delivery were studied at San Borja Hospital in Santiago, Chile.

Pregnant women prior to delivery had significantly higher values of accelerator globulin, antihemophilic globulin, proconvertin complex and Stuart-Prower factor than adult controls, but there was no difference in specific prothrombin.

The coagulation factors were similar in premature infants without RDS as compared to those with RDS (lived and died combined). However, premature infants with RDS who lived had higher values of prothrombin, proconvertin complex, Stuart-Prower factor at 25 hrs and accelerator globulin at 55 hrs of age than those with RDS who died. Most of these findings could be explained by impaired liver function in association with hypoxia.

* Supported in part by grants-in-aid from the University of Colorado Fluid Research Committee, OTH Grant (HE 06684) and NIH Grant (HD 23584).


** Dr. Markarian performed this study during the tenure of a USPHS Postdoctoral Research Fellowship.


 
  • References

  • 1 Aballi A. J, de Lamerens S. Coagulation Changes in the Neonatal Period and in Early Infancy. Pediat. Clin. N. Amer 9 (Suppl. 03) 785 1962;
  • 2 McElfresh A. E. Coagulation During the Neonatal Period. Amer. J. med. Sci 242: 771 1961;
  • 3 Githens J. H, Fevrier P. E. Changing Concepts in the Etiology and Treatment of Bleeding Diseases of the Newborn. Quart. Rev. Pediat 14: 141 1959;
  • 4 Ehling L. R. Hemorrhagic Disease of the Newborn. Amer. J. Dis. Child 101: 242 1961;
  • 5 Dam H, Dyggve H, Larsen H, Plum P. The Relation of Vitamin K Deficiency to Hemorrhagic Disease of the Newborn. Advanc. Pediat 5: 129 1952;
  • 6 Ehling R. E, Markarian M, Githens J. H, Lubchenco L. O. Coagulation Factors in Prematures with and without Respiratory Distress. Abstract, Society for Pediatric Research, June, 1964, p. 87.
  • 7 Aballi A. J. The Action of Vitamin K in the Neonatal Period. 5th. med. J. (Bgham, Ala.) 58 (Suppl. 01) 48 1965;
  • 8 Blystad W, Landing B. H, Smith G. A. Pulmonary Hyaline Membranes in Newborn Infants. Statistical, Morphologic and Experimental Study of Their Nature, Occurrence and Significance. Pediatrics 8: 5 1951;
  • 9 Miller H. G, Jennison M. H. Study of Pulmonary Hyaline-Like Material in 4117 Consecutive Births. Incidence, Pathogenesis and Diagnosis. Pediatrics 5: 7 1950;
  • 10 Driscoll S. G, Smith G. A. Neonatal Pulmonary Disorders. Pediat. Clin. N. Amer 9 (2): 325 1962;
  • 11 Larrieu M. J, Soulier J. P, Minkowski A. Le Sang du Cordon Ombilical: Étude Complète de la Coagulabilité, Comparaison avec le Sang Maternel. Étud. néo-natal 1: 1 1952;
  • 12 Breton A, Goudemand M, Hutin A, Gaudrelier J. R, Gaudier B. Étude de la Coagulabilité Sanguine chez le Nouveau-Né Prémature. Arch, franç. Pédiat 17: 143 1960;
  • 13 Salazar de Sousa G. Clotting Factors in Newborn. Étud. néo-natal 5: 97 1956;
  • 14 Fresh J. W, Ferguson J. H, Lewis J. H. Blood-Clotting Studies in Parturient Women and the Newborn. Obstet. Gynec 7: 117 1956;
  • 15 Markarian M, Jackson J. J, Bannon A. Thromboelastographic Studies in Premature Infants with and without the Respiratory Distress Syndrome: Serial Determinations Including Fibrinogen, Hematocrits, pH and Thrombin Times. Part I. Submitted to Thrombos. Diathes. haemorrh. (Stuttg.)
  • 16 Sacrez R, Mayer G, Mayer S, Levy J. M. Hémorragies du Nouveau-Né et Troubles de l’Hémostase. Arch, franç. Pediat 17: 1126 1960;
  • 17 Usher R. The Respiratory Distress Syndrome of Prematurity : A Preliminary Report. Pediat. int. (Roma) 9: 141 1959;
  • 18 Rudolph A. M, Drorbaugh J. E, Auld P. A. M, Rudolph A. J, Nadas A. J, Smith G. A, Hubbell J. P. Studies in the Circulation in the Neonatal Period. The Circulation in the Respiratory Distress Syndrome. Pediatrics 27: 551 1961;
  • 19 Neligan G. A, Oxon D. M, Smith G. The Blood Pressure of Newborn Infants in Asphyxiai States and in Hyaline Membrane Disease. Pediatrics 26: 735 1960;
  • 20 Graig W. S. Intracranial Hemorrhage in the New-Born: A Study of Diagnosis and Differential Diagnosis Based Upon Pathological and Clinical Findings in 126 Cases. Arch. Dis. Child 12: 89 1938;
  • 21 McKay D. G. Disseminated Intravascular Coagulation. An Intermediary Mechanism of Disease. New York, Evanston and London: Hoeber Medical Division, Harper and Row, Publishers; 1965
  • 22 Hardaway R. M. The Role of Intravascular Clotting in the Etiology of Shock. Ann. Surg 155: 325 1962;
  • 23 Hardaway R. M, Brune W. H, Geever E. F, Burns J. W, Mock H. P. Studies on the Role of Intravascular Coagulation in Irreversible Hemorrhagic Shock. Ann. Surg 155: 241 1962;
  • 24 Hardaway R. M, McKay D. G. The Syndromes of Disseminated Intravascular Coagulation. Rev. Surg 20: 297 1963;
  • 25 Rodriguez-Erdmann F. Bleeding Due to Increased Intravascular Blood Coagulation: Hemorrhagic Syndromes Caused by Consumption of Blood Clotting Factors (Consumption Coagulopathies). New Engl. J. Med 273: 1370 1965;
  • 26 Owren P. A, Ass K. The Control of Dicumarol Therapy and the Quantitative Determination of Prothrombin and Proconvertin. Scand. J. clin. Lab. Invest 3: 201 1951;
  • 27 Borchgrevink C. F, Pool J. G, Stormorken H. A New Assay for Factor V (Proaccelerin-Accelerin) Using Russell’s Viper Venom. J. Lab. clin. Med 55: 625 1960;
  • 28 Bachmann F, Duckert F, Koller F. The Stuart-Prower Factor Assay and its Clinical Significance. Thrombos. Diathes. haemorrh. (Stuttg.) 2: 24 1958;
  • 29 Proctor R, Rapaport S. The Partial Thromboplastin Time with Kaolin. Amer. J. clin. Path 5/5: 212 1961;
  • 30 Kasper G. K, Hoag M. S, Aggelar P. M, Stone S. Blood Clotting Factors in Pregnancy: Factor VIII Concentrations in Normal and AHF-Deficient Women. Obstet. Gynec 24: 242 1964;
  • 31 Talbert L. M, Langdell R. D. Normal Values of Certain Factors in the Blood Clotting Mechanism in Pregnancy. Amer. J. Obstet. Gynec 90: 44 1964;
  • 32 Loeliger A, Koller F. Behavior of Factor VII and Prothrombin in Late Pregnancy and in the Newborn. Acta haemat. (Basel) 7: 157 1952;
  • 33 Pechet L, Alexander B. Increased Clotting Factors in Pregnancy. New Engl. J. Med 265: 1093 1961;
  • 34 Davidson E, Tomlin S. The Levels of the Plasma Coagulation Factors after Trauma and Childbirth. J. clin. Path 16: 112 1963;
  • 35 Ratnoff O. D, Golopy J. E, Pritchard J. A. The Blood Clotting Mechanism During Normal Parturition. J. Lab. clin. Med 44: 408 1954;
  • 36 Taylor P. M. Concentration of Fibrinogen in the Plasma of Normal Newborn Infants. Pediatrics 19: 233 1957;
  • 37 Markarian M, Jackson J. J, Bannon A. Thromboelastographic Studies in Pregnant Women. In preparation.
  • 38 Hathaway W. E, Henderson B. J. Effect of Hypoxia on Coagulation Factors in the Newborn. (In preparation.)
  • 39 Crowell J. W, Houston B. Effect of Acidity on Blood Coagulation. Amer. J. Physiol 202: 379 1961;
  • 40 Hardaway R. M, Elovitz M. J, Brewster Jr. W. R, Houchin D. N. Clotting Time of Heparinized Blood: Influence of Acidosis. Arch. Surg 89: 701 1964;
  • 41 Crowell J. W, Sharpe G. P, Lambright R. L, Read W. L. The Mechanism of Death after Resuscitation Following Acute Circulating Failure. Surgery 38: 696 1955;
  • 42 Larroche J. C. Hémorragies Cérébrales Intra-Ventriculaires Chez le Prémature. Part I. Anatomie et Physiopathologie. Biol. Neonat 7: 26 1964;
  • 43 Marburg O, Casamajor L. Phlebostasis and Phlebothrombosis of the Brain in the Newborn and in Early Childhood. Arch. Neurol. Psychiat 52: 170 1944;
  • 44 Malamud N, Itabashi H. H, Castor J, Messinger H. B. An Etiologic and Diagnostic Study of Cerebral Palsy. J. Pediat 65: 270 1964;
  • 45 Schwartz P. Birth Injuries of the Newborn. Arch. Pediat 73: 429 1956;